Concepedia
Statistics
Publications
9
Citations
2.4K
H-Index
Active since
1989
Affiliations
Clinical Research Atlanta(Current)
Medical University of Vienna
Humanitas University
University of California San Diego
The University of Texas at San Antonio Health Science Center
Paul Hellstern is an author at Clinical Research Atlanta specializing in pharmacotherapy, medicine, and inflammation.
Publications per year
1989–2021
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text
Medicine, Internal Medicine, Pharmacology +8
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
Séverine Vermeire, William J. Sandborn, Silvio Danese et al. · The Lancet · 2017 · 197 citations
Life Sciences, Immunology, Pharmacotherapy +14
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)
Silvio Danese, Séverine Vermeire, Paul Hellstern et al. · Gut · 2017 · 178 citations · Full text
Veterinary Medicine, Immunology, Pharmacotherapy +17
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
Paul J. Pockros, Michael Fuchs, B. Freilich et al. · Liver International · 2019 · 158 citations
Medicine, Pharmacology, Pharmacotherapy +14
1–5 of 9